Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sheryl Kunning"'
Autor:
Tracy Tabib, Robert Lafyatis, Seungwon Kim, Robert Ferris, Ayana Ruffin, Angen Liu, Sayali Onkar, Sheryl Kunning, Caleb Lampenfeld, Irina Abecassis, Zengbiao Qi, Ryan Soose, Umamaheswar Duvvuri, Steffi Oesterrich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f6e0a0e4255140dcb1c7ad966f3bca20
Autor:
Dario A.A. Vignali, Tullia C. Bruno, Robert L. Ferris, Evan J. Lipson, John M. Kirkwood, James G. Herman, Simon C. Watkins, Daniel P. Normolle, Dhivyaa Rajasundaram, Rebekah Dadey, Michael Calderon, Sonali Joyce, Maria Velez, Lauren Oliveri, Sheryl Kunning, Creg J. Workman, Caleb Lampenfeld, Anthony R. Cillo, Ashwin Somasundaram
Supplementary Data from Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d13871b3cf1b46ea9183ef5677559a
https://doi.org/10.1158/2326-6066.22544399.v1
https://doi.org/10.1158/2326-6066.22544399.v1
Autor:
Dario A.A. Vignali, Tullia C. Bruno, Robert L. Ferris, Evan J. Lipson, John M. Kirkwood, James G. Herman, Simon C. Watkins, Daniel P. Normolle, Dhivyaa Rajasundaram, Rebekah Dadey, Michael Calderon, Sonali Joyce, Maria Velez, Lauren Oliveri, Sheryl Kunning, Creg J. Workman, Caleb Lampenfeld, Anthony R. Cillo, Ashwin Somasundaram
Many cancer patients do not develop a durable response to the current standard-of-care immunotherapies, despite substantial advances in targeting immune inhibitory receptors. A potential compounding issue, which may serve as an unappreciated, dominan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b05fcf9dd223d5a61e7bb44a68f9198
https://doi.org/10.1158/2326-6066.c.6550631.v1
https://doi.org/10.1158/2326-6066.c.6550631.v1
Autor:
Ashwin Somasundaram, Anthony R. Cillo, Caleb Lampenfeld, Creg J. Workman, Sheryl Kunning, Lauren Oliveri, Maria Velez, Sonali Joyce, Michael Calderon, Rebekah Dadey, Dhivyaa Rajasundaram, Daniel P. Normolle, Simon C. Watkins, James G. Herman, John M. Kirkwood, Evan J. Lipson, Robert L. Ferris, Tullia C. Bruno, Dario A.A. Vignali
Publikováno v:
Cancer Immunol Res
Many cancer patients do not develop a durable response to the current standard-of-care immunotherapies, despite substantial advances in targeting immune inhibitory receptors. A potential compounding issue, which may serve as an unappreciated, dominan
Autor:
Noor Nader, Dongyan Liu, Hye Mi Kim, Ayana Ruffin, Sheryl Kunning, Xiaron Zhang, Daniel Dunlap, Roy Semaan, Rajeev Dhupar, Adam Soloff, Tullia Bruno
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Feng Shan, Anthony Cillo, Carly Cardello, Daniel Yuan, Sheryl Kunning, Jian Cui, Robert Ferris, Tullia Bruno, Creg Workman, Panayiotis Benos, Dario Vignali
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Hye Mi Kim, Dongyan Liu, Ayana Ruffin, Alexandra McDonough, Caleb Lampenfeld, Sheryl Kunning, Ashwin Somasundaram, Laura Stabile, Tullia Bruno
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Anthony Cillo, Carly Cardello, Lilit Karapetyan, Feng Shan, Cindy Sander, Elizabeth Rush, Aofei Li, Arivarasan Karunamurthy, Sheryl Kunning, John Kirkwood, Tullia Bruno, Dario Vignali
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Robert L. Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T. Ruffin, Carly Reeder, James Ohr, William E. Gooding, Seungwon Kim, Brian J. Karlovits, Dario A.A. Vignali, Umamaheswar Duvvuri, Jonas T. Johnson, Daniel Petro, Dwight E. Heron, David A. Clump, Tullia C. Bruno, Julie E. Bauman
Publikováno v:
Clin Cancer Res
Purpose: Concurrent radiotherapy with cetuximab, an anti-EGFR mAb, is a standard treatment for locally advanced head and neck squamous carcinoma (HNSCC). Cytotoxic T lymphocyte antigen-4–positive (CTLA-4+) regulatory T cells (Treg) dampen cellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8e0c45e8ea3a1fb53d59db2ef9ccb8
https://europepmc.org/articles/PMC9164766/
https://europepmc.org/articles/PMC9164766/
Autor:
Chang Liu, Lawrence C. Andrews, Caleb Lampenfeld, Dario A. A. Vignali, W. Paul Duprex, Alison Morris, Anuradha Ray, Sham Nambulli, Sheryl Kunning, Jishnu Das, Bryan J. McVerry, Georgios D Kitsios, Creg J. Workman, Janet S. Lee, Alok J Joglekar, Ashwin Somasundaram, Carly Cardello, Prabir Ray, Gaurav Deshmukh, Harinder Singh, Barbara Methé, Ayana T. Ruffin, Anthony R. Cillo, Stephanie Grebinowski, Tullia C. Bruno, Panayiotis V. Benos, Sayali Onkar, Yingze Zhang, Feng Shan
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection presents with varied clinical manifestations1, ranging from mild symptoms to acute respiratory distress syndrome (ARDS) with high mortality2,3. Despite extensive analyses, there remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffdf225aa4acbbf2e942132cdf340018
https://doi.org/10.1101/2021.02.10.430499
https://doi.org/10.1101/2021.02.10.430499